|
P2767
|
|
1,2-Di(cis-9-octadecenoyl)-sn-glycerol 3-phosphate sodium salt ≥99% (GC), ≥97% (TLC)
|
|
|
|
|
|
P3716
|
|
1,2-Didecanoyl-sn-glycerol 3-phosphate sodium salt ≥99% (TLC)
|
|
|
|
|
|
D8769
|
|
1,2-Dimyristoyl-rac-glycerol ~99%
|
|
|
|
|
|
P3650
|
|
1,2-Dimyristoyl-sn-glycero-3-phosphate monosodium salt ≥99%
|
|
|
|
|
|
P3591
|
|
1,2-Dioctanoyl-sn-glycerol 3-phosphate sodium salt ≥99%
|
|
|
|
|
|
P4013
|
|
1,2-Dipalmitoyl-sn-glycero-3-phosphate sodium salt ≥99%
|
|
|
|
|
|
D9135
|
|
1,2-Dipalmitoyl-sn-glycerol ~99%
|
|
|
|
|
|
12279
|
|
1,2-Propanediol analytical standard
|
|
|
|
|
|
D107204
|
|
1,3-Dihydroxyacetone dimer 97%
|
|
|
|
|
|
D9144
|
|
1,3-Dimyristin ~99%
|
|
|
|
|
|
81780
|
|
1,3-Propanediol puriss., ≥99.0% (GC)
|
|
|
|
|
|
13368
|
|
1-Deoxy-D-xylulose-5-phosphate sodium salt ≥99.0% (TLC)
|
Metabolite of the non-mevalonate pathway, generally found in prokaryotes, as precursor to isoprenoids as well as non-isoprenoids like vitamins. As this pathway is not present in humans, it is of interest for the development of bacterium-specific drugs in the search for treatments of infectious diseases.
|
|
|
|
|
M1765
|
|
1-Lauroyl-rac-glycerol ≥99%
|
Monolaurin (1-Lauroyl-rac-glycerol) is used as an antimicrobial agent in various formulas and microemulsions and as a methane mitigation agent in ruminants.
|
|
|
|
|
M7640
|
|
1-Linoleoyl-rac-glycerol ≥97%, liquid
|
Monolinolein (1-Linoleoyl-rac-glycerol) is used in the development of pH-responsive lyotropic liquid crystals for controlled drug delivery.
|
|
|
|
|
M7890
|
|
1-Monopalmitoleoyl-rac-glycerol ~99%
|
Monopalmitolein is used in comparative studies of the antimicrobial activity of monoglycerides such as monocaprin, and monlaurin.
|
|
|
|
|
M7765
|
|
1-Oleoyl-rac-glycerol ≥99%
|
Monoolein (1-Oleoyl-rac-glycerol) is used in the development of monoolein-based nanoparticulate liquid dispersions as possible vehicles for drug delivery.
|
|
|
|
|
96566
|
|
1-Propanol analytical standard
|
|
|
|
|
|
M2015
|
|
1-Stearoyl-rac-glycerol ≥99%
|
|
|
|
|
|
76184
|
|
3-Palmitoyl-sn-glycerol ≥99.0% (TLC)
|
|
|
|
|
|
P9511
|
|
3-sn-Phosphatidic acid sodium salt from egg yolk lecithin ≥98%
|
|
|
|
|
|
P8877
|
|
D-(−)-3-Phosphoglyceric acid disodium salt ≥93%, powder
|
3-Phosphoglyceric acid is an intermediate in glycolysis. It also a precursor in the formation of serine.
|
|
|
|
|
49800
|
|
D-(+)-Glyceraldehyde ≥98.0% (HPLC), viscous
|
|
|
|
|
|
367494
|
|
D-Glyceric acid calcium salt dihydrate 99%
|
|
|
|
|
|
M1640
|
|
DL-α-Palmitin ≥99%
|
α-Monopalmitin is a glycerol esterified fatty acid, monoacylglycerol, found in lipid structures such as ceramides. 1-Palmitoylglycerol may be used as a substrate for the identification and differentiation of enzymes that hydrolyze or transfer monoacylglycerols such as neuropathy target esterase(s) and monoacylglycerol acyltransferase(s) (MAG).
|
|
|
|
|
A6625
|
|
Acetylcholine chloride ≥99% (TLC)
|
Acetylcholine chloride, injected at 20 mg/kg body weight, reduces mortality and plasma proinflammatory cytokines in mice with experimentally-induced sepsis 1. The cholinergicanti-infl ammatory mechanism is probably mediated by interaction of acetylcholine with α7n cholinoreceptor on monocytes, macrophages, and neutrophils, which decreases the levels of proinflammatory cytokines such as TNF-α, IL-1β, and IL-6.
|
|
|
|
|
C7017
|
|
Choline chloride ≥99%
|
Choline is an essential nutrient, commonly grouped with the B complex vitamins, that plays key roles in many biological processes. The enzymatic activities of butyrylcholinesterase (BChE) and paraoxonase 1 (PON1), two serum enzymes synthesized by the liver and related with inflammation, were decreased in a sepsis animal model injected with LPS. Choline chloride administered intravenously at 20 mg/kg body weight prevents the LPS-mediated decreases in the activities of these two enzymes .
|
|
|
|
|
26978
|
|
Choline chloride BioUltra, ≥99.0% (AT)
|
Choline is an essential nutrient, commonly grouped with the B complex vitamins, that plays key roles in many biological processes. The enzymatic activities of butyrylcholinesterase (BChE) and paraoxonase 1 (PON1), two serum enzymes synthesized by the liver and related with inflammation, were decreased in a sepsis animal model injected with LPS. Choline chloride administered intravenously at 20 mg/kg body weight prevents the LPS-mediated decreases in the activities of these two enzymes 1.
|
|
|
|
|
D7137
|
|
Dihydroxyacetone phosphate dilithium salt ≥93% (enzymatic)
|
Dihydroxyacetone phosphate (DHAP) is a metabolic intermediate involved in many pathways, including glycolysis, gluconeogenesis, glycerol metabolism, phosphatidic acid synthesis, fat metabolism, and the Calvin cycle.
|
|
|
|
|
51269
|
|
Dihydroxyacetone phosphate hemimagnesium salt hydrate ≥95% (TLC)
|
Dihydroxyacetone phosphate (DHAP) is a metabolic intermediate involved in many pathways, including glycolysis, gluconeogenesis, glycerol metabolism, phosphatidic acid synthesis, fat metabolism, and the Calvin cycle.
|
|
|
|
|
49767
|
|
Glycerol BioUltra, for molecular biology, anhydrous, ≥99.5% (GC)
|
|
|
|
|
|
D1639
|
|
Glyceryl 1,3-dipalmitate ≥99%
|
|
|
|
|
|
D8269
|
|
Glyceryl 1,3-distearate ≥99% (TLC)
|
|
|
|
|
|
T5376
|
|
Glyceryl triacetate ≥99%
|
|
|
|
|
|
T8626
|
|
Glyceryl tributyrate ≥99%
|
|
|
|
|
|
T7517
|
|
Glyceryl tridecanoate ≥99% (GC)
|
|
|
|
|
|
T4891
|
|
Glyceryl tridodecanoate ≥99%
|
|
|
|
|
|
T7379
|
|
Glyceryl trielaidate ≥99%
|
|
|
|
|
|
T2151
|
|
Glyceryl triheptadecanoate ≥99%
|
|
|
|
|
|
T9517
|
|
Glyceryl trilinoleate ≥98% (TLC), liquid
|
|
|
|
|
|
T6513
|
|
Glyceryl trilinolenate ≥97% (TLC), liquid
|
|
|
|
|
|
T5141
|
|
Glyceryl trimyristate ≥99%
|
|
|
|
|
|
T4632
|
|
Glyceryl trinonadecanoate ≥99%
|
|
|
|
|
|
T9126
|
|
Glyceryl trioctanoate ≥99%
|
|
|
|
|
|
92860
|
|
Glyceryl trioleate ≥97.0% (TLC)
|
|
|
|
|
|
T7140
|
|
Glyceryl trioleate ≥99%
|
|
|
|
|
|
T5888
|
|
Glyceryl tripalmitate ≥99%
|
|
|
|
|
|
T5909
|
|
Glyceryl tripalmitelaidate ≥99%
|
|
|
|
|
|
T2630
|
|
Glyceryl tripalmitoleate ≥98%, liquid
|
|
|
|
|
|
T5016
|
|
Glyceryl tristearate ≥99%
|
|
|
|
|
|
T1412
|
|
Glyceryl tritricosanoate ≥99%
|
|
|
|
|
|
T3882
|
|
Glyceryl tritridecanoate ≥99%
|
|
|
|
|
|
T5534
|
|
Glyceryl triundecanoate ≥98%
|
|
|
|
|
|
L3265
|
|
Lipoteichoic acid from Bacillus subtilis
|
Lipoteichoic acid (LTA) is a complex component of cell walls of Gram-positive bacteria that are involved in a wide range of cell processes such as the stimulation of immune responses and cell signaling pathways. LTA differs between species of gram-positive bacteria. Lipoteichoic acid from Bacillus subtilis may be used to compare its structure, immunogenicity and functions versus other bacterial LTAs. Lipoteichoic acid (LTA) is a teichoic acid attached to a lipid abundant on Gram-positive bacteria cell wall. LTA is a pathogen-associated molecular-patterns (PAMP) recognized by Toll-like receptor 2 (TLR2), This recognition leads to the activation of NF-kB.
|
|
|
|
|
L2515
|
|
Lipoteichoic acid from Staphylococcus aureus bacterial cell wall polymer
|
Lipoteichoic acid (LTA) is a complex component of cell walls of Gram-positive bacteria that are involved in a wide range of cell processes such as the stimulation of immune responses and cell signaling pathways. LTA differs between species of gram-positive bacteria. Lipoteichoic acid from Streptococcus aureus may be used to compare its structure, immunogenicity and functions versus other bacterial LTAs. Lipoteichoic acid (LTA) is a teichoic acid attached to a lipid abundant on Gram-positive bacteria cell wall. LTA is a pathogen-associated molecular-patterns (PAMP) recognized by Toll-like receptor 2 (TLR2), This recognition leads to the activation of NF-kB.
|
|
|
|
|
L4015
|
|
Lipoteichoic acid from Streptococcus faecalis
|
Lipoteichoic acid (LTA) is a complex component of cell walls of Gram-positive bacteria that are involved in a wide range of cell processes such as the stimulation of immune responses and cell signaling pathways. LTA differs between species of gram-positive bacteria. Lipoteichoic acid from Streptococcus faecalis may be used to compare its structure, immunogenicity and functions versus other bacterial LTAs.
|
|
|
|
|
L3140
|
|
Lipoteichoic acid from Streptococcus pyogenes
|
|
|
|
|
|
P0503
|
|
O-Phosphorylethanolamine
|
|
|
|
|
|
75347
|
|
Oleoyl-L-α-lysophosphatidic acid sodium salt ≥96.0% (TLC)
|
Endogenous agonist for LPA1 and LPA2 receptors. LPA does not induce angiogenesis, but has effects on endothelial cell physiology that are similar to those of sphingosine 1-phosphate. Induces cell migration of cancer and non-cancer cells. LPA, a bioactive lipid and a ligand for P2Y5 (a G protein-coupled receptor) , plays an importnt role in the maintenance of human hair growth 1.
|
|
|
|
|
L7260
|
|
Oleoyl-L-α-lysophosphatidic acid sodium salt ≥98%, solid
|
Endogenous agonist for LPA1 and LPA2 receptors. LPA does not induce angiogenesis, but has effects on endothelial cell physiology that are similar to those of sphingosine 1-phosphate. Induces cell migration of cancer and non-cancer cells.
|
|
|
|
|
P0378
|
|
Phosphocholine chloride calcium salt tetrahydrate Sigma Grade
|
|
|
|
|
|
538124
|
|
Propionaldehyde reagent grade, 97%
|
|
|
|
|
|
T4257
|
|
Tripentadecanoin ≥99%
|
|
|
|
|
|
T5784
|
|
Tripetroselaidin ≥99%
|
|
|
|
|
|
M1890
|
|
rac-Glycerol 1-myristate ≥99%
|
rac-Glycerol 1-myristate, a 1-monoglyceride of myristic acid, has antibacterial activity against several Gram-positive bacterial strains.
|
|
|
|
|
G2138
|
|
rac-Glycerol 1-phosphate disodium salt hydrate ≥85% (enzymatic)
|
rac-Glycerol 1-phosphate was shown to be produced in mammalian tiβues by the hydrolysis of rac-glycerol 1:2-cyclic phosphate by a soluble phosphodiesterase. 2
|
|
|
|
|
G7886
|
|
sn-Glycerol 3-phosphate bis(cyclohexylammonium) salt ≥93%
|
|
|
|
|